Cargando…
Soluble suppression of tumorigenesis-2 is a strong predictor of all-cause, cardiovascular and infection-related mortality risk in haemodialysis patients with diabetes mellitus
BACKGROUND: Soluble suppression of tumorigenesis-2 (sST2) is a strong prognostic biomarker of cardiovascular (CV) disease. End-stage kidney disease (ESKD) patients are at high risk of CV events and infections. Herein we investigated the utility of sST2 to predict all-cause and cause-specific mortali...
Autores principales: | Hammer, Fabian, Genser, Bernd, Dieplinger, Benjamin, Egger, Margot, Müller, Thomas, Drechsler, Christiane, März, Winfried, Störk, Stefan, Wanner, Christoph, Krane, Vera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494540/ https://www.ncbi.nlm.nih.gov/pubmed/36158148 http://dx.doi.org/10.1093/ckj/sfac142 |
Ejemplares similares
-
Recurrent cardiovascular events in patients with type 2 diabetes and haemodialysis: analysis from the 4D Study
por: Marx, Nikolaus, et al.
Publicado: (2023) -
Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients
por: Drechsler, Christiane, et al.
Publicado: (2011) -
Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients
por: Drechsler, Christiane, et al.
Publicado: (2013) -
Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients
por: Winkler, Karl, et al.
Publicado: (2008) -
Risk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitus
por: Müller, Michael, et al.
Publicado: (2020)